Clinical trial reportJournal of clinical pharmacologyPublished
Nipocalimab Phase 3 Dose Selection for Severe Hemolytic Disease of the Fetus and Newborn
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Journal of clinical pharmacology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Erythroblastosis, Fetal; Receptors, Fc; Histocompatibility Antigens Class I; Pregnancy; Dose-Response Relationship, Drug; Models, Biological; Adult; Infant, Newborn; Female; Antibodies, Monoclonal, Humanized; Dose Selection
- PubMed ID
- 42726505
- PubMed Central ID
- PMC13565270
- Open access
- Yes, open
- Added to directory
- Source checked